Platform|API|Archive|Contact
Humanexa SignalsPharmaceutical Intelligence
Subscribe
Signals
Regulatory
  • FDA
  • EMA
  • MHRA
  • PMDA
  • Health Canada
Clinical
  • Phase I
  • Phase II
  • Phase III
  • Readouts
  • Enrollment Signals
Competitive
  • Pipeline Tracking
  • Company Moves
  • Asset Intelligence
  • Landscape Reports
Markets
  • Pricing
  • Access
  • Commercial
  • Launch Tracking
M&A Watch
  • Licensing
  • Acquisitions
  • Partnerships
  • Capital Raises
StrategyCatalystsPricing
Humanexa Signals

Data-driven pharmaceutical intelligence for biotech investors, pharma operators, consultants, and intelligence teams.

Powered by Humanexa

Categories

  • Regulatory
  • Clinical
  • Competitive
  • Markets
  • M&A Watch
  • Strategy
  • Catalyst Tracker

Company

  • Pricing
  • Partner with us
  • Subscribe
  • Contact
  • Privacy

Subscribe to Humanexa Signals

Weekly intelligence for pharma decision-makers.

No paywall. No spam. Unsubscribe anytime.

© 2026 Humanexa Signals. All rights reserved.

Intelligence powered by the Humanexa engine.

Therapeutic Area

Analgesia

Therapeutic area intelligence for Analgesia with 6 indexed intelligence signals across regulatory, clinical, competitive, and market developments.

Signals
6
Catalysts
0
Companies
0

Companies

No related entities indexed yet.

Assets

Hydromorphone →
Intranasal →
Intrathecal →
Liposomal →
YZJ-4729 →

Recent signals(6)

ClinicalAugust 7, 2026

Intrathecal Morphine Study Aims to Reduce Postoperative Pain in Thoracic Surgery

A randomized, placebo-controlled trial is investigating the efficacy of intrathecal morphine for pain management in video-assisted and robotic-assisted thoracic surgery.

ClinicalJuly 30, 2026

Liposomal Bupivacaine May Enhance Analgesia in Hip Fracture Surgery

A clinical trial is investigating the efficacy of liposomal bupivacaine for pain management in older patients post-hip fracture surgery.

ClinicalJuly 26, 2026

Study on Hydromorphone in Multimodal Analgesia for Knee Arthroplasty

The study evaluates the efficacy of hydromorphone combined with ropivacaine for pain management in knee arthroplasty.

ClinicalJuly 12, 2026

Study on Quadro-Iliac Plane Block for Pain Control Post-Lumbar Microdiscectomy

This study compares ultrasound-guided quadro-iliac plane block with local infiltration analgesia for postoperative pain control.

ClinicalJuly 7, 2026

YZJ-4729 Shows Promise in Phase Ⅱ Trial for Postoperative Pain Relief

A Phase Ⅱ study is evaluating the efficacy and safety of YZJ-4729 in patients with moderate to severe acute pain after abdominal surgery.

ClinicalJuly 6, 2026

Intranasal and IV Oxytocin Study for Pain Relief Shows Potential

A clinical trial is investigating the efficacy of oxytocin administered intranasally and intravenously for pain reduction.

Upcoming catalysts

No catalysts indexed for this entity yet.

Indications

No related entities indexed yet.

Newsletter

Get signals before the market moves

Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.

No paywall. No spam. Unsubscribe anytime.